ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 138 filers reported holding ARCELLX INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,098,719 | -27.1% | 643,777 | -35.8% | 2.13% | -39.5% |
| Q2 2023 | $31,683,208 | -17.6% | 1,001,999 | -19.7% | 3.52% | -11.6% |
| Q1 2023 | $38,455,409 | +12.6% | 1,248,147 | +13.2% | 3.98% | -18.7% |
| Q4 2022 | $34,153,808 | +46.8% | 1,102,447 | -11.1% | 4.90% | +55.0% |
| Q3 2022 | $23,273,000 | +41.5% | 1,239,913 | +36.3% | 3.16% | +23.2% |
| Q2 2022 | $16,448,000 | +18.5% | 909,739 | -8.1% | 2.57% | +43.4% |
| Q1 2022 | $13,876,000 | – | 989,739 | – | 1.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $99,440,000 | 48.67% |
| AJU IB Investment Co., Ltd. | 1,380,890 | $24,966,000 | 48.34% |
| NEA Management Company, LLC | 6,750,264 | $112,703,000 | 5.79% |
| Samsara BioCapital, LLC | 1,063,835 | $19,234,000 | 5.13% |
| Novo Holdings A/S | 4,016,878 | $72,625,000 | 3.58% |
| CLOUGH CAPITAL PARTNERS L P | 1,165,533 | $20,953,000 | 2.60% |
| Soleus Capital Management, L.P. | 909,739 | $16,448,000 | 2.57% |
| CAXTON CORP | 101,719 | $1,839,000 | 2.47% |
| Cormorant Asset Management, LP | 1,525,000 | $27,572,000 | 2.08% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,470,559 | $44,668,000 | 1.70% |